Contract 75F40124P00263
Twinstrand Biosciences Inc · Department Of Health And Human Services · June 27, 2024
Twinstrand Biosciences Inc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on June 27, 2024 for $50,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Seattle, WA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 10, 2026.
Contract details
- PIID
- 75F40124P00263
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Seattle, WA
- First action
- June 27, 2024
- Latest action
- February 10, 2026
Description
TWINSTRAND DUPLEX SEQUENCING MUTAGENESIS KIT
Modification timeline
-
February 10, 2026Mod P00002 · Other Administrative Action$50.0K
-
September 16, 2024Mod P00001 · Other Administrative Action$50.0K
-
June 27, 2024Base award$50.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40124P00263?
Contract 75F40124P00263 is a federal contract awarded to Twinstrand Biosciences Inc by Department Of Health And Human Services on June 27, 2024 for $50,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75F40124P00263?
Twinstrand Biosciences Inc won contract 75F40124P00263 from Department Of Health And Human Services.
How much is contract 75F40124P00263 worth?
Contract 75F40124P00263 has obligated $50,000 to date.